Frequent epigenetic inactivation of the chaperone SGNE1/7B2 in human gliomas
- PMID: 21901745
- DOI: 10.1002/ijc.26416
Frequent epigenetic inactivation of the chaperone SGNE1/7B2 in human gliomas
Abstract
In a genome-wide screen using DMH (differential methylation hybridization) we have identified a CpG island within the 5' region and untranslated first exon of the secretory granule neuroendocrine protein 1 gene (SGNE1/7B2) that showed hypermethylation in low- and high-grade astrocytomas compared to normal brain tissue. Pyrosequencing was performed to confirm the methylation status of this CpG island in 89 astrocytic gliomas of different malignancy grades and six glioma cell lines. Hypermethylation of SGNE1/7B2 was significantly more frequent in diffuse low-grade astrocytomas as well as secondary glioblastomas and anaplastic astrocytomas as compared to primary glioblastomas. mRNA expression analysis by real-time RT-PCR indicates that SGNE1/7B2 expression is downregulated in astrocytic gliomas compared to white matter samples. Treatment of glioma cells with the demethylating agent 5-aza-2'-deoxycytidine restores the transcription of SGNE1/7B2. Overexpression of SGNE1/7B2 in T98G, A172 and U373MG glioblastoma cells significantly suppressed focus formation and led to a significant increase in apoptotic cells as determined by flow cytometric analysis in T98G cells. In summary, we have identified SGNE1/7B2 as a novel target silenced by DNA methylation in astrocytic gliomas. The high incidence of this alteration and the significant effects of SGNE1/7B2 on the growth and apoptosis of glioblastoma cells provide a first proof for a functional implication of SGNE1/7B2 inactivation in the molecular pathology of gliomas.
Copyright © 2011 UICC.
Similar articles
-
SGNE1/7B2 is epigenetically altered and transcriptionally downregulated in human medulloblastomas.Oncogene. 2007 Aug 16;26(38):5662-8. doi: 10.1038/sj.onc.1210338. Epub 2007 Mar 5. Oncogene. 2007. PMID: 17334394
-
Epigenetic silencing of the protocadherin family member PCDH-gamma-A11 in astrocytomas.Neoplasia. 2005 Mar;7(3):193-9. doi: 10.1593/neo.04490. Neoplasia. 2005. PMID: 15799819 Free PMC article.
-
Promoter hypermethylation of multiple genes in astrocytic gliomas.Int J Oncol. 2003 Mar;22(3):601-8. Int J Oncol. 2003. PMID: 12579314
-
Global DNA Methylation Patterns in Human Gliomas and Their Interplay with Other Epigenetic Modifications.Int J Mol Sci. 2019 Jul 15;20(14):3478. doi: 10.3390/ijms20143478. Int J Mol Sci. 2019. PMID: 31311166 Free PMC article. Review.
-
Genetic and epigenetic contribution to astrocytic gliomas pathogenesis.J Neurochem. 2019 Jan;148(2):188-203. doi: 10.1111/jnc.14616. Epub 2018 Dec 3. J Neurochem. 2019. PMID: 30347482 Review.
Cited by
-
Downregulation of TES by hypermethylation in glioblastoma reduces cell apoptosis and predicts poor clinical outcome.Eur J Med Res. 2014 Dec 11;19(1):66. doi: 10.1186/s40001-014-0066-4. Eur J Med Res. 2014. PMID: 25498217 Free PMC article.
-
Hexa-D-arginine treatment increases 7B2•PC2 activity in hyp-mouse osteoblasts and rescues the HYP phenotype.J Bone Miner Res. 2013 Jan;28(1):56-72. doi: 10.1002/jbmr.1738. J Bone Miner Res. 2013. PMID: 22886699 Free PMC article.
-
A Composite Bioinformatic Analysis to Explore Endoplasmic Reticulum Stress-Related Prognostic Marker and Potential Pathogenic Mechanisms in Glioma by Integrating Multiomics Data.J Oncol. 2022 Oct 4;2022:9886044. doi: 10.1155/2022/9886044. eCollection 2022. J Oncol. 2022. PMID: 36245971 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials